Top compounds associated with response to MRPL15


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.049 0.2
mRNA neopeltolide CTRPv2 pan-cancer AAC 0.1 0.2
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC -0.056 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.051 0.2
mRNA BRD6340 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA EKB-569 GDSC1000 pan-cancer AAC 0.046 0.2
mRNA brivanib CTRPv2 pan-cancer AAC 0.05 0.2
mRNA SU11274 CTRPv2 pan-cancer AAC 0.05 0.2
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.046 0.2
Download CSV